Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only/idempotent annotations, the description discloses substantial behavior: internal cascading lookups that replace 2-3 manual lookups, graceful degradation when GLEIF/OpenFIGI are unavailable, ambiguity handling via figi_candidates, explicit unresolved identifiers, and source-labelled results. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but dense and purpose is front-loaded with the example query patterns and the 'Use FIRST' trigger. Some redundancy with the schema exists, but the extra length is earned by the tool's complexity and edge cases.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Even without an output schema, the description explains return semantics (canonical IDs with source labels, figi_candidates on ambiguous matches, explicit unresolved list) and failure modes (degraded LEI/FIGI enrichment). It covers supported types, input constraints, fallback behavior, and the multi-lookup nature, making it sufficient for correct invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds meaningful parameter nuance: concrete input examples (AAPL, 0000320193, ozempic) and the critical bond-issuer caveat that the full noun phrase must not be passed. It enriches the schema rather than repeating it.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states the exact operation: resolving user-spoken names to canonical/official identifiers, illustrated with concrete verbs and resources (ticker, CIK, LEI, RxCUI). It distinguishes supported entity types (company vs drug) and clarifies that the result feeds other tools requiring these identifiers. This makes the tool's role unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID,' which is actionable guidance for an agent. It does not explicitly name sibling tools or state when NOT to use it, though the tool's niche is clear enough that exclusion is mostly implied.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation1/5

There is severe overlap among tools: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-identical variants, and deep_research, discover_tools, and suggest_questions all serve discovery/research purposes. The Discogs-specific tools are distinct, but the large number of redundant Pipeworx tools makes it impossible to tell which one to pick.

Naming Consistency2/5

The Discogs tools follow a clean verb_noun pattern (get_artist, get_label, get_master, get_release), but the majority of the set uses inconsistent, domain-specific names (deep_research, generate_llms_txt, polymarket_arbitrage, scan_competitor_ai_presence). No single naming convention is applied across the server.

Tool Count1/5

With 36 tools, the server is massively over-provisioned for a Discogs-focused API. Most tools (e.g., ask_pipeworx, polymarket_edges, SEC lookups) have nothing to do with Discogs and belong to a separate service. The Discogs surface alone could be served by ~6 tools (search, get_artist, get_label, get_master, get_release, search_within), so the count is wildly inappropriate.

Completeness3/5

For the Discogs domain, the core entities (artist, label, master, release) and full-text search are present, plus semantic search inside records. However, there are gaps like user collections, wantlists, marketplace, and discogs-specific filters beyond format/country. The presence of many unrelated tools does not directly hurt domain coverage, but the Discogs surface is not exhaustive.